Chordate System Prophylactic Migraine Clinical Investigation

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

December 31, 2015

Conditions
Migraine
Interventions
DEVICE

Chordate System S200 + CT100 (active treatment)

Chordate S200 + CT100 (active treatment) gives Kinetic Oscillation Stimulation for 15 minutes to each nostril and by that giving an effect on the autonomic nervous system (ANS).

DEVICE

Chordate System S200 + CT100 (placebo treatment)

Chordate S200 + CT100 (placebo) is used in the same way as Active treatment, but no Kinetic Oscillation Stimulation is given. Catheter is not inflated and no vibration is given.

Trial Locations (4)

11433

Neurolgy Clinic, Stockholm

25220

Stortorgets neurologmottagning, Helsingborg

582 19

Läkarcentrum Stångåblick, Linköping

162 68

Neurologmottagningen Vällingby sjukhus, Vällingby

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Chordate Medical

INDUSTRY

NCT02243865 - Chordate System Prophylactic Migraine Clinical Investigation | Biotech Hunter | Biotech Hunter